Acne Clearing Toner

Manufacturer
GLYTONE LLC
Effective date
2024-06-28
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 00:14:26

Label at a glance#

ProductAcne Clearing Toner
Active ingredientSALICYLIC ACID
Label structure7 sections

Dosage and administration

After cleansing, apply toner to a cotton pad and gently apply over affected area one to three times daily. Do not rinse. Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two to three times daily if needed or as directed by a doctor. If bothersome dryness or peeling occurs, reduce application to once a day or every toher day.

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Salicylic Acid 2%

Purpose

OTC - PURPOSE SECTION

Acne Treatment

Use

INDICATIONS & USAGE SECTION

For the treatment of acne.

  • Dries and clears acne blemishes and allows skin to heal.
  • Penetrates pores to eliminate most acne blemishes, blackheads, and whiteheads.
  • Helps prevent the development of new acne blemishes, blackheads, and whiteheads.

Warnings

WARNINGS SECTION

For external use only.

Flammable

OTHER SAFETY INFORMATION

Keep away from fire or flame

When using this product

OTC - WHEN USING SECTION

  • skin irritation and dryness is more likely to occur if you use another topical acne medication at the same time. If irritation occurs, only use one topical acne medication at a time.
  • avoid contact with eyes. If eye contact occurs, rinse thoroughly with water.

Stop use and ask a doctor

OTC - STOP USE SECTION

if rash occurs.

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

  • After cleansing, apply toner to a cotton pad and gently apply over affected area one to three times daily.
  • Do not rinse.
  • Because excessive drying of the skin may occur, start with one application daily, then gradually increase to two to three times daily if needed or as directed by a doctor.
  • If bothersome dryness or peeling occurs, reduce application to once a day or every toher day.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

WATER, ISOPROPRYL ALCOHOL, ACETONE, BENZALKONIUM CHLORIDE, FRAGRANCE/PARFUM, POLYSORBATE 20, RED 40, YELLOW 5

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

GLYTONE

ACNE CLEARING TONER

ACNE THERAPY

2% SALICYLIC ACID

240 mL / 8.0 FL. OZ.

acneacne

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
c6f86816-7da6-43ea-8c25-ac9758311cc5Product name120220118
dea2eded-d1e7-46bb-9a3d-f8dc20de6277Product name120190408
252e11b6-1a9a-4283-a242-df2c129c496dProduct name320170717

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
84262-011-01Acne Clearing Toner240 mL in 1 BOTTLELIQUID2401
84262-011-01Acne Clearing Toner1 in 1 CARTONLIQUID11

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
84262-011ACNE CLEARING TONER (SALICYLIC ACID) LIQUID [GLYTONE LLC]12 package rows20240630_1bf555e0-6f0f-966d-e063-6294a90aee95.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 26 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84262-01184262-011-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 25 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
1bf555e0-6f10-966d-e063-6294a90aee951bf555e0-6f0f-966d-e063-6294a90aee952024-06-28WarningsExact identifier
spl id: 1bf555e0-6f10-966d-e063-6294a90aee95
spl set id: 1bf555e0-6f0f-966d-e063-6294a90aee95

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.